UnitedHealth Group Inc. (NYSE:UNH) – Stock analysts at Leerink Swann increased their Q3 2016 earnings per share estimates for shares of UnitedHealth Group in a report issued on Monday. Leerink Swann analyst A. Gupte now anticipates that the firm will post earnings per share of $2.10 for the quarter, up from their prior estimate of $2.07. Leerink Swann currently has a “Outperform” rating on the stock. Leerink Swann also issued estimates for UnitedHealth Group’s Q4 2016 earnings at $2.10 EPS.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The company earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the firm earned $1.77 EPS.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Other equities analysts also recently issued reports about the stock. Mizuho upped their price target on shares of UnitedHealth Group from $160.00 to $169.00 and gave the company a “buy” rating in a research note on Wednesday. Barclays PLC upped their price target on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a research note on Wednesday, July 20th. Royal Bank Of Canada upped their price target on shares of UnitedHealth Group from $157.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 20th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price target on the stock in a research note on Friday, July 22nd. Finally, Vetr downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price target on the stock. in a research note on Tuesday. Two analysts have rated the stock with a hold rating, twenty-four have given a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $155.28.

Shares of UnitedHealth Group (NYSE:UNH) traded up 1.59% during trading on Wednesday, reaching $145.67. 2,551,462 shares of the company traded hands. The stock has a market capitalization of $138.73 billion, a PE ratio of 22.80 and a beta of 0.57. The company has a 50-day moving average of $137.12 and a 200-day moving average of $136.75. UnitedHealth Group has a 12 month low of $107.51 and a 12 month high of $145.74.

Institutional investors have recently modified their holdings of the company. Van Hulzen Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC boosted its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares in the last quarter. Hanson McClain Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares in the last quarter. Howe & Rusling Inc. boosted its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. Institutional investors own 85.80% of the company’s stock.

In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.65% of the company’s stock.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is 39.12%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.